TVTX- Travere Therapeutics, Inc.

Name: Travere Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Travere Therapeutics, Inc. (TVTX) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. TVTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Dube Eric M	432.9K	$23.14M	-
Other	Heerma Peter	138.6K	$7.41M	-
Other	Rote William E.	123.1K	$6.58M	-
CFO	Cline Christopher R.	116.9K	$6.25M	-
Other	Inrig Jula	111.5K	$5.96M	-

Activity

Buys and sells only

Transactions

10 filings · page 16

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 17, 2021	Aselage Steve80	Director	Sale+OE	17,727	$27.44	$486,456.12	-4.4%	-46.4%	-11.5%
Feb 18, 2021	Rote William E.58	Senior Vice President, R&D	Sell	2,500	$28.01	$70,025.00	-3.4%	-	-
Feb 8, 2021	Rosenberg Noah L.	Chief Medical Officer	Sell	2,250	$31.50	$70,863.75	-2.3%	-	-
Feb 8, 2021	Heerma Peter53	Chief Commercial Officer	Sell	2,250	$31.50	$70,863.75	-1.8%	-	-
Feb 8, 2021	Rote William E.58	Senior Vice President, R&D	Sell	4,500	$31.50	$141,727.50	-5.5%	-	-
Feb 8, 2021	Reed Elizabeth E58	SVP, GC &Corporate Secretary	Sell	4,500	$31.50	$141,727.50	-5.5%	-	-
Feb 8, 2021	Clague Laura64	Chief Financial Officer	Sell	4,500	$31.50	$141,727.50	-6.3%	-	-
Feb 8, 2021	Dube Eric M57	Chief Executive Officer	Sell	9,626	$31.50	$303,170.87	-2.9%	-	-
Feb 3, 2021	Reed Elizabeth E58	SVP, GC &Corporate Secretary	Sell	3,175	$28.91	$91,789.25	-4.0%	-	-
Feb 3, 2021	Clague Laura64	Chief Financial Officer	Sell	3,625	$28.91	$104,798.75	-5.2%	-	-

← PrevPage 16Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC